GYRE
Gyre Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$8.070
Haut
$8.070
Bas
$8.070
Volume
0.15M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously
Gyre Therapeutics' Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China
Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002).Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for
Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an
Actions Connexes
ALBT
Avalon GloboCare Corp.
BSL
Blackstone Senior Floating Rate 2027 Term Fund Common Shares of Beneficial Interest
GATEW
Marblegate Acquisition Corp. Warrant
SMPL
The Simply Good Foods Company
NAPA
The Duckhorn Portfolio Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.